The coronavirus disease-19 (COVID-19) pandemic caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused widespread morbidity and …

The current pandemic caused by the novel coronavirus, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), continues to relentlessly rage across the globe, representing a …

During the COVID‐19 pandemic, immunoglobulins (IG) have been suggested both as an
immunosuppressive treatment in late COVID‐19 stages and as an antiviral in pre‐exposure …

Abstract The coronavirus disease‐19 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) challenged globally with its morbidity …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has become a huge obstacle
to the health system due to the high rate of contagion. It is postulated that intravenous …

Objectives Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …

Abstract Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has …

Abstract Background Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG) is
an unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID …

Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

Abstract Treatment with immunomodulators, such as intravenous immunoglobulin (IVIG),
may attenuate inflammatory responses observed in the severe stages of acute respiratory …